After a busy week in the IPO market, just one biotech is scheduled to go public in the week ahead.
NASH biotech 89bio (ETNB) plans to raise $85 million at a $225 million market cap. The company’s target indication represents a multi...read more
Two companies and two SPACs entered the public market this week, while Karat Packaging (KRAT) postponed and withdrew its $40 million IPO. Two companies and one SPAC submitted initial filings. Post spin-off BellRing Brands (BRBR) priced...read more
Innate Pharma, a commercial-stage French biotech developing antibody therapies for cancer, raised $69 million by offering 12.5 million shares at $5.50 (€4.97), a 13% discount to its prior closing price on the Euronext Paris (€5.71; ticker IPH)....read more
After disappointing debuts from tech unicorns and biotechs, a highly profitable billion-dollar consumer staples company is set to lead up to four IPOs raising $660 million in the week ahead.
Post spinoff BellRing Brands (BRBR) is on track...read more
US IPO Week Ahead: Just 1 biotech is on the calendar in a slow week for the IPO market
After a busy week in the IPO market, just one biotech is scheduled to go public in the week ahead. NASH biotech 89bio (ETNB) plans to raise $85 million at a $225 million market cap. The company’s target indication represents a multi...read more
US IPO Weekly Recap: Post’s BellRing Brands pops 17% in a 4-IPO week
Two companies and two SPACs entered the public market this week, while Karat Packaging (KRAT) postponed and withdrew its $40 million IPO. Two companies and one SPAC submitted initial filings. Post spin-off BellRing Brands (BRBR) priced...read more
French cancer biotech Innate Pharma prices US IPO at $5.50
Innate Pharma, a commercial-stage French biotech developing antibody therapies for cancer, raised $69 million by offering 12.5 million shares at $5.50 (€4.97), a 13% discount to its prior closing price on the Euronext Paris (€5.71; ticker IPH)....read more
US IPO Week Ahead: Post’s BellRing Brands to ring the bell in a 3-IPO week
After disappointing debuts from tech unicorns and biotechs, a highly profitable billion-dollar consumer staples company is set to lead up to four IPOs raising $660 million in the week ahead. Post spinoff BellRing Brands (BRBR) is on track...read more